array:23 [ "pii" => "S0210480607737713" "issn" => "02104806" "doi" => "10.1016/S0210-4806(07)73771-3" "estado" => "S300" "fechaPublicacion" => "2007-01-01" "aid" => "73771" "copyright" => "Asociación Española de Urología (AEU)" "copyrightAnyo" => "2007" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Actas Urol Esp. 2007;31:1100-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 4463 "formatos" => array:3 [ "EPUB" => 7 "HTML" => 4088 "PDF" => 368 ] ] "itemSiguiente" => array:18 [ "pii" => "S0210480607737725" "issn" => "02104806" "doi" => "10.1016/S0210-4806(07)73772-5" "estado" => "S300" "fechaPublicacion" => "2007-01-01" "aid" => "73772" "copyright" => "Asociación Española de Urología (AEU)" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Actas Urol Esp. 2007;31:1107-16" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 485 "formatos" => array:3 [ "EPUB" => 6 "HTML" => 228 "PDF" => 251 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Expresion del receptor de esteroides y xenobioticos (SXR) y del gen de multirresistencia drogas (MDR1) y de los polimorfismos de las enzimas GSTs, SULTs y CYP en tumores vesicales profundos, analisis de su expresion y correlación con otros factores pronósticos" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "1107" "paginaFinal" => "1116" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Steroid and xenobiotic receptor (sxr), multidrug resistance gene (mdr1) and gsts, sults and cyp polymorphism expression in invasive bladder cancer, analysis of their expression and correlation with other prognostic factors" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. Rioja Zuazu, E. Bandrés Elizalde, D. Rosell Costa, A. Rincón Mayans, J. Zudaire Bergera, Mª.J. Gil Sanz, L.A. Rioja Sanz, J. García Foncillas, J.Mª. Berián Polo" "autores" => array:9 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Rioja Zuazu" ] 1 => array:2 [ "nombre" => "E." "apellidos" => "Bandrés Elizalde" ] 2 => array:2 [ "nombre" => "D." "apellidos" => "Rosell Costa" ] 3 => array:2 [ "nombre" => "A." "apellidos" => "Rincón Mayans" ] 4 => array:2 [ "nombre" => "J." "apellidos" => "Zudaire Bergera" ] 5 => array:2 [ "nombre" => "Mª.J." "apellidos" => "Gil Sanz" ] 6 => array:2 [ "nombre" => "L.A." "apellidos" => "Rioja Sanz" ] 7 => array:2 [ "nombre" => "J." "apellidos" => "García Foncillas" ] 8 => array:2 [ "nombre" => "J.Mª." "apellidos" => "Berián Polo" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210480607737725?idApp=UINPBA00004N" "url" => "/02104806/0000003100000010/v1_201304251853/S0210480607737725/v1_201304251853/es/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0210480607737701" "issn" => "02104806" "doi" => "10.1016/S0210-4806(07)73770-1" "estado" => "S300" "fechaPublicacion" => "2007-01-01" "aid" => "73770" "copyright" => "Asociación Española de Urología (AEU)" "documento" => "article" "crossmark" => 0 "subdocumento" => "rev" "cita" => "Actas Urol Esp. 2007;31:1089-99" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1226 "formatos" => array:3 [ "EPUB" => 6 "HTML" => 686 "PDF" => 534 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Estrategias para la biopsia de próstata. Revisión de la literatura" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "1089" "paginaFinal" => "1099" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Prostate biopsy strategies. a review of the literature" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Ramírez Backhaus, M. Trassierra Villa, S. Arlandis Guzmán, F. Delgado Oliva, F. Boronat Tormo, J.F. Jiménez Cruz" "autores" => array:6 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Ramírez Backhaus" ] 1 => array:2 [ "nombre" => "M." "apellidos" => "Trassierra Villa" ] 2 => array:2 [ "nombre" => "S." "apellidos" => "Arlandis Guzmán" ] 3 => array:2 [ "nombre" => "F." "apellidos" => "Delgado Oliva" ] 4 => array:2 [ "nombre" => "F." "apellidos" => "Boronat Tormo" ] 5 => array:2 [ "nombre" => "J.F." "apellidos" => "Jiménez Cruz" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210480607737701?idApp=UINPBA00004N" "url" => "/02104806/0000003100000010/v1_201304251853/S0210480607737701/v1_201304251853/es/main.assets" ] "es" => array:14 [ "idiomaDefecto" => true "titulo" => "Seguridad del ácido zoledrómico en el control del dolor en el estadio M1b del cáncer de próstata" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "1100" "paginaFinal" => "1106" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "M. Álvarez-Múgica, J.Mª Fernández Gómez, A. Jalón Monzón, R.C. González Álvarez, J. García Rodríguez, J.L. Martín Benito" "autores" => array:6 [ 0 => array:4 [ "nombre" => "M." "apellidos" => "Álvarez-Múgica" "email" => array:1 [ 0 => "malvarezmug@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "cor0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "aff0005" ] ] ] 1 => array:3 [ "nombre" => "J.Mª" "apellidos" => "Fernández Gómez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "A." "apellidos" => "Jalón Monzón" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "aff0005" ] ] ] 3 => array:3 [ "nombre" => "R.C." "apellidos" => "González Álvarez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "aff0005" ] ] ] 4 => array:3 [ "nombre" => "J." "apellidos" => "García Rodríguez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "aff0005" ] ] ] 5 => array:3 [ "nombre" => "J.L." "apellidos" => "Martín Benito" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "aff0005" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:3 [ "entidad" => "Servicio de Urología 1. Hospital Universitario Central de Asturias. Oviedo. Asturias" "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "1" "correspondencia" => "Correspondencia autor: Dr. M. Álvarez-Múgica Servicio de Urología 1 Hospital Universitario Central de Asturias Celestino Villamil, s/n - 33006-Oviedo (Asturias) Tel.: 985108000 (extensión 38143)" ] ] ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Use of zoledromic acid on pain control in stages m1b of prostate cancer" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2007-03-01" "fechaAceptado" => "2007-06-01" "PalabrasClave" => array:2 [ "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec88420" "palabras" => array:3 [ 0 => "Ácido Zoledrómico" 1 => "Metástasis óseas" 2 => "Dolor óseo" ] ] ] "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec88419" "palabras" => array:3 [ 0 => "Zoledromic acid" 1 => "Bone methastasis" 2 => "Bone pain" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<span class="elsevierStyleSectionTitle">Objetivos</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Valorar el uso del ácido zoledrómico en el control del dolor de las metástasis óseas en el cáncer de próstata, así como estudiar su seguridad y efectos secundarios.</p> <span class="elsevierStyleSectionTitle">Material y métodos</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Se incluyeron en el estudio 37 pacientes consecutivos diagnosticados de cáncer de próstata con metástasis óseas entre los años 2005 y 2006 a los que se administró una dosis de 4 mg de Zometa® mensual durante una media de 10,24 meses, recogiéndose unos datos según un protocolo establecido.</p> <span class="elsevierStyleSectionTitle">Resultados</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">En cuanto al control del dolor, observamos como en 8 de los 20 pacientes a los que se les administró Zometa®, el control fue absoluto, en 6 de estos se consiguió un control parcialmente bueno (permitiendo una buena actividad diaria), en 4 el control fue parcialmente malo (empeorando su calidad de vida), mientras que 2 pacientes presentaron mal control del dolor. Respecto a los efectos adversos del Zometa®, no observamos ningún efecto secundario en ninguno de nuestros pacientes ni durante la inyección del fármaco ni posteriormente, si bien en 2 pacientes se suspendió el tratamiento por su mal estado general.</p> <span class="elsevierStyleSectionTitle">Conclusiones</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">El futuro de este tratamiento reside en saber si la administración precoz de este fármaco puede prevenir o retrasar la aparición de las metástasis, (merced a su actividad antitumoral demostrada), no sólo en las debidas al cáncer de próstata si no también a metástasis óseas secundarias a otros tumores genito-urinarios.</p>" ] "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span class="elsevierStyleSectionTitle">Objectives</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">To probe the use of Zoledromic acid in the control of the pain due to bone methastasis of a prostate cancer.</p> <span class="elsevierStyleSectionTitle">Material and method</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">We included in our study 37 consecutive patients diagnosed of prostate cancer who developed bone methastasis during 2005 and 2006 to whom we gave a 4 mg dose of Zoledromic acid during a mean time of 10.24 months.</p> <span class="elsevierStyleSectionTitle">Results</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">We observed a complete control of the pain in 8 of the 20 patients, and partially in 6 of those patients. We did not evaluate any adverse reaction due to this treatment.</p> <span class="elsevierStyleSectionTitle">Conclusions</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">We still yet to know whether the administration of this treatment in the early stages of the prostate cancer could prevent or retard the appearance of bone methastasis.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "Referencias" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:12 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Ferlay J, Bray F, Pissani P, Parkin DM. Globocan 2000.Cancer incidence, mortality and prevalence worldwide, version 1.0.LARC Cancerbase no. 5.Lyon: IARCPress: 2001" ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tendencias epidemiológicas en el cáncer de próstata durante los últimos años" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M. Luján Galán" 1 => "A. Páez Borda" 2 => "V. Chiva Robles" 3 => "C. Santonja Garriga" 4 => "I. Romero Cajigal" 5 => "Sánchez A. Berenguer" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Arch Esp Urol" "fecha" => "2004" "volumen" => "57" "numero" => "8" "paginaInicial" => "817" "paginaFinal" => "825" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15560270" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epidemiological trends in prostate cancer over the last years" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M. Luján Galán" 1 => "A. Páez Borda" 2 => "V. Chiva Robles" 3 => "C. Santonja Garriga" 4 => "I. Romero Cajigal" 5 => "A. Berenguer Sánchez" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Arch Esp Urol" "fecha" => "2004" "volumen" => "57" "numero" => "8" "paginaInicial" => "817" "paginaFinal" => "825" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15560270" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epidemiology of prostate cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "G.P. Hass" 1 => "W.A. Sakr" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "CA Cancer J Clin" "fecha" => "1997" "volumen" => "47" "numero" => "5" "paginaInicial" => "273" "paginaFinal" => "285" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9314822" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "B.I. Carlin" 1 => "G.L. Andriole" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Cancer" "fecha" => "2000" "volumen" => "88" "numero" => "12 Suppl" "paginaInicial" => "2989" "paginaFinal" => "2994" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10898342" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Berruti" 1 => "L. Dogliotti" 2 => "R. Bitossi" 3 => "G. Fasolis" 4 => "G. Gorzegno" 5 => "M. Bellina" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "J Urol" "fecha" => "2000" "volumen" => "164" "numero" => "4" "paginaInicial" => "1248" "paginaFinal" => "1253" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10992374" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Long term efficacy of zoledromic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F. Saad" 1 => "D.M. Gleason" 2 => "R. Murray" 3 => "S. Tchekmedyian" 4 => "P. Venner" 5 => "L. Lacombe" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "J Natl Cancer Inst" "fecha" => "2004" "volumen" => "96" "numero" => "11" "paginaInicial" => "879" "paginaFinal" => "882" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15173273" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The impact of skeletal-related events on health related quality of life on patients with metastatic prostate cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "K.P. Weinfurt" 1 => "Y. Li" 2 => "L.J. Castel" 3 => "J.W. Timbie" 4 => "A. Glendenning" 5 => "K.A. Schulman" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Ann Oncol" "fecha" => "2002" "volumen" => "13" "numero" => "suppl 5" "paginaInicial" => "180" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Understanding the experience of pain in terminally ill patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "S.C. Weiss" 1 => "L.L. Emanuel" 2 => "D.L. Fairclough" 3 => "E.J. Emanuel" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(00)04515-3" "Revista" => array:7 [ "tituloSerie" => "Lancet" "fecha" => "2001" "volumen" => "357" "numero" => "9265" "paginaInicial" => "1311" "paginaFinal" => "1315" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11343734" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "T. Meuser" 1 => "C. Pietruck" 2 => "L. Radbruch" 3 => "P. Stute" 4 => "K.A. Lehmann" 5 => "S. Grond" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Pain" "fecha" => "2001" "volumen" => "93" "numero" => "3" "paginaInicial" => "247" "paginaFinal" => "257" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11514084" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cancer statistics 1999" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S.H. Landis" 1 => "J. Murria" 2 => "S. Bolden" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "CA Cancer J Clin" "fecha" => "1999" "volumen" => "49" "numero" => "1" "paginaInicial" => "8" "paginaFinal" => "31" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10200775" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Zoledronic acid is effective in preventing and delaying skeletal events in patients with bone metastases secondary to genitourinary cancers" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "F. Saad" 1 => "A. Lipton" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1464-410X.2005.05740.x" "Revista" => array:7 [ "tituloSerie" => "BJU Int" "fecha" => "2005" "volumen" => "96" "numero" => "7" "paginaInicial" => "964" "paginaFinal" => "969" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16225510" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "es" "url" => "/02104806/0000003100000010/v1_201304251853/S0210480607737713/v1_201304251853/es/main.assets" "Apartado" => array:4 [ "identificador" => "6429" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Original" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/02104806/0000003100000010/v1_201304251853/S0210480607737713/v1_201304251853/es/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210480607737713?idApp=UINPBA00004N" ]
Journal Information
Seguridad del ácido zoledrómico en el control del dolor en el estadio M1b del cáncer de próstata
Use of zoledromic acid on pain control in stages m1b of prostate cancer